COVID vaccine by Oxford gains positive results

Monday, 26 October 2020 - 17:29

The COVID-19 vaccine developed by the University of Oxford and is manufactured by AstraZeneca Plc has triggered lower adverse responses among the elderly. 

Speaking in this regard, AstraZeneca spokesperson added that “It is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the COVID-19 disease severity is higher.” 

The elderly is observed as one of the most vulnerable groups for COVID-19 and the news that an experimental vaccine triggers an immune response is seen in a positive light.

Special notice to all State hospitals
Thursday, 06 May 2021 - 15:50

Chief Epidemiologist of the Epidemiology Unit, Dr Sudath Samaraweera stated that the Ministry of Health has requested all main State Hospitals to set up... Read More

Health guidelines issued for locations selling liquor
Thursday, 06 May 2021 - 15:22

Commissioner General of Excise issues health guidelines for liquor selling bars, pubs & restaurants in line with guidelines issued by the Director... Read More

Helmet that fight against COVID-19 (Video)
Thursday, 06 May 2021 - 15:05

A research team at the Kelaniya University had managed to develop a new helmet that can protect the wearer against the COVID-19 virus. The helmet which... Read More